Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis i

Journal of Inherited Metabolic Disease

Volumn 33, Issue 4, 2010, Pages 421-427

  Thomas, Janet A ^a,g   Beck, Michael ^b   Clarke, Joe T R ^c   Cox, Gerald F ^d,e,f  

^a UNIVERSITY OF COLORADO   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d GENZYME CORPORATION   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MALFORMATION; CARDIOMYOPATHY; CARPAL TUNNEL SYNDROME; CAUCASIAN; CLINICAL FEATURE; COARSE FACE; COGNITIVE DEFECT; CORNEA DISEASE; DELAYED DIAGNOSIS; FEMALE; HEPATOMEGALY; HERNIA; HUMAN; HURLER SYNDROME; JOINT CONTRACTURE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; REGISTER; SCHEIE SYNDROME; SPINAL CORD DISEASE; VALVULAR HEART DISEASE; AGE DISTRIBUTION; CARDIOMYOPATHIES; CHILD; DISEASE COURSE; INFANT; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS I; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SPINAL CORD DISEASES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; CARDIOMYOPATHIES; CARPAL TUNNEL SYNDROME; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS I; PREVALENCE; REGISTRIES; SPINAL CORD DISEASES; YOUNG ADULT;

EID: 77956063405     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9113-7     Document Type: Article

References (17)

1. P Arn JE Wraith L Underhill 2009 Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I Registry J Pediatr 154 6 859 864 10.1016/j.jpeds.2008.12.024 19217123 e853
2. EA Braunlin JM Berry CB Whitley 2006 Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I Am J Cardiol 98 3 416 418 10.1016/j.amjcard.2006.02.047 1:CAS:528:DC%2BD28XntVWjtrw%3D 16860035
3. R Cimaz S Vijay C Haase, et al. 2006 Attenuated type I mucopolysaccharidosis in the differential diagnosis of juvenile idiopathic arthritis: a series of 13 patients with Scheie syndrome Clin Exp Rheumatol 24 2 196 202 1:STN:280:DC%2BD28zltVelsQ%3D%3D 16762159
4. LA Clarke JE Wraith M Beck, et al. 2009 Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I Pediatrics 123 1 229 240 10.1542/peds.2007-3847 19117887
5. O Gabrielli LA Clarke S Bruni GV Coppa 2009 Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up Pediatrics 125 1 e183 e187 10.1542/peds.2009-1728 20026495
6. R Giugliani VM Rojas AM Martins, et al. 2009 A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I Mol Genet Metab 96 1 13 19 10.1016/j.ymgme.2008.10.009 1:CAS:528:DC%2BD1cXhsFajsrfI 19038563
7. ED Kakkis J Muenzer GE Tiller, et al. 2001 Enzyme-replacement therapy in mucopolysaccharidosis I N Engl J Med 344 3 182 188 10.1056/NEJM200101183440304 1:CAS:528:DC%2BD3MXosleksw%3D%3D 11172140
8. PJ Meikle JJ Hopwood AE Clague WF Carey 1999 Prevalence of lysosomal storage disorders JAMA 281 3 249 254 10.1001/jama.281.3.249 1:STN:280: DyaK1M7hsFSguw%3D%3D 9918480
9. J Muenzer JE Wraith LA Clarke 2009 Mucopolysaccharidosis I: management and treatment guidelines Pediatrics 123 1 19 29 10.1542/peds.2008-0416 19117856
10. Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver C, Beaudet A, Sly W et al (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 3421-3452
11. GM Pastores P Arn M Beck, et al. 2007 The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I Mol Genet Metab 91 1 37 47 10.1016/j.ymgme.2007.01.011 1:CAS:528:DC%2BD2sXkt1ehuro%3D 17336562
12. HG Scheie GW Hambrick Jr LA Barness 1962 A newly recognized forme fruste of Hurler's disease (gargoylism) Am J Ophthalmol 53 753 769 1:STN:280: DyaF38%2FpvFOhuw%3D%3D 14498144
13. RE Stevenson RR Howell VA McKusick, et al. 1976 The iduronidase-deficient mucopolysaccharidoses: clinical and roentgenorgraphic features Pediatrics 57 1 111 122 1:STN:280:DyaE287gtF2itw%3D%3D 813180
14. T Vieira I Schwartz V Munoz, et al. 2008 Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis? Am J Med Genet A 146A 13 1741 1747 10.1002/ajmg.a.32320 18546277
15. S Vijay JE Wraith 2005 Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type I Acta Paediatr 94 7 872 877 10.1080/08035250510031584 16188808
16. JE Wraith 2005 The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I Expert Opin Pharmacother 6 3 489 506 10.1517/14656566.6.3.489 1:CAS:528:DC%2BD2MXjvVyrtrk%3D 15794739
17. JE Wraith LA Clarke M Beck, et al. 2004 Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase) J Pediatr 144 5 581 588 10.1016/j.jpeds.2004.01.046 1:CAS:528:DC%2BD2cXjs1Wnsbg%3D 15126990